ASX - By Stock
|
IIQ |
Re:
IIQ General Discussion
|
|
Locked
|
228 |
117K |
2 |
12:06 |
12:06 |
ASX - By Stock
|
228
|
117K
|
2
|
|
ASX - By Stock
|
MEM |
Re:
Ann: Investor Presentation
|
|
Locked
|
15 |
4.5K |
0 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
15
|
4.5K
|
0
|
|
ASX - By Stock
|
MEM |
Re:
Ann: Investor Presentation
|
|
Locked
|
15 |
4.5K |
7 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
15
|
4.5K
|
7
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
Locked
|
11K |
6.0M |
6 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
11K
|
6.0M
|
6
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Chart
|
|
Locked
|
19K |
11M |
10 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
19K
|
11M
|
10
|
|
ASX - By Stock
|
PNV |
Re:
Ann: Chairman address to Bell Potter Healthcare Conference
|
|
Locked
|
60 |
20K |
1 |
18/11/23 |
18/11/23 |
ASX - By Stock
|
60
|
20K
|
1
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
Locked
|
11K |
6.0M |
3 |
08/09/23 |
08/09/23 |
ASX - By Stock
|
11K
|
6.0M
|
3
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
Locked
|
11K |
6.0M |
6 |
07/09/23 |
07/09/23 |
ASX - By Stock
|
11K
|
6.0M
|
6
|
|
ASX - By Stock
|
MEM |
Re:
Ann: Preliminary Final Report
|
|
Locked
|
5 |
2.1K |
2 |
30/08/23 |
30/08/23 |
ASX - By Stock
|
5
|
2.1K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Locked
|
1.0K |
399K |
2 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
399K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Locked
|
1.0K |
399K |
6 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
399K
|
6
|
|
ASX - By Stock
|
MEM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Locked
|
12 |
4.0K |
3 |
28/07/23 |
28/07/23 |
ASX - By Stock
|
12
|
4.0K
|
3
|
|
ASX - By Stock
|
MEM |
Re:
Ann: Half Yearly Report and Accounts
|
|
Locked
|
4 |
2.0K |
1 |
24/02/23 |
24/02/23 |
ASX - By Stock
|
4
|
2.0K
|
1
|
|
ASX - By Stock
|
MEM |
Re:
Ann: KOL testings demonstrate Felix System outperforms DGC
|
|
Locked
|
29 |
8.8K |
1 |
07/02/23 |
07/02/23 |
ASX - By Stock
|
29
|
8.8K
|
1
|
|
ASX - By Stock
|
MEM |
Re:
Ann: FELIX System commercialisation, regulatory plan and trial
|
|
Locked
|
28 |
7.7K |
2 |
24/10/22 |
24/10/22 |
ASX - By Stock
|
28
|
7.7K
|
2
|
|
ASX - By Stock
|
MEM |
Re:
Ann: Preliminary Final Report
|
|
Locked
|
6 |
2.2K |
4 |
31/08/22 |
31/08/22 |
ASX - By Stock
|
6
|
2.2K
|
4
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
Locked
|
11K |
6.0M |
1 |
09/08/22 |
09/08/22 |
ASX - By Stock
|
11K
|
6.0M
|
1
|
|
ASX - By Stock
|
MEM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Locked
|
114 |
40K |
0 |
12/04/22 |
12/04/22 |
ASX - By Stock
|
114
|
40K
|
0
|
|
ASX - By Stock
|
MEM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Locked
|
114 |
40K |
5 |
12/04/22 |
12/04/22 |
ASX - By Stock
|
114
|
40K
|
5
|
|
ASX - By Stock
|
MEM |
Re:
Ann: Follow up sales of FelixTM System
|
|
Locked
|
50 |
14K |
0 |
08/04/22 |
08/04/22 |
ASX - By Stock
|
50
|
14K
|
0
|
|
ASX - By Stock
|
MEM |
Re:
Ann: Follow up sales of FelixTM System
|
|
Locked
|
50 |
14K |
2 |
01/04/22 |
01/04/22 |
ASX - By Stock
|
50
|
14K
|
2
|
|
ASX - By Stock
|
PNV |
Re:
Ann: Amendment to Managing Directors LTI
|
|
Locked
|
90 |
27K |
5 |
07/07/21 |
07/07/21 |
ASX - By Stock
|
90
|
27K
|
5
|
|
ASX - By Stock
|
MEM |
Re:
Ann: Felix device - V&V progress and KOL study update
|
|
Locked
|
35 |
14K |
5 |
25/06/21 |
25/06/21 |
ASX - By Stock
|
35
|
14K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Thoughts
|
|
Locked
|
29 |
9.3K |
1 |
01/06/21 |
01/06/21 |
ASX - By Stock
|
29
|
9.3K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Thoughts
|
|
Locked
|
29 |
9.3K |
2 |
01/06/21 |
01/06/21 |
ASX - By Stock
|
29
|
9.3K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Thoughts
|
|
Locked
|
29 |
9.3K |
1 |
31/05/21 |
31/05/21 |
ASX - By Stock
|
29
|
9.3K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Thoughts
|
|
Locked
|
29 |
9.3K |
0 |
31/05/21 |
31/05/21 |
ASX - By Stock
|
29
|
9.3K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Thoughts
|
|
Locked
|
29 |
9.3K |
1 |
31/05/21 |
31/05/21 |
ASX - By Stock
|
29
|
9.3K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Thoughts
|
|
Locked
|
29 |
9.3K |
0 |
31/05/21 |
31/05/21 |
ASX - By Stock
|
29
|
9.3K
|
0
|
|
ASX - By Stock
|
MSB |
Thoughts
|
|
Locked
|
29 |
9.3K |
2 |
31/05/21 |
31/05/21 |
ASX - By Stock
|
29
|
9.3K
|
2
|
|
ASX - By Stock
|
IIQ |
Re:
Chart Thread
|
|
Locked
|
1.4K |
554K |
2 |
17/03/21 |
17/03/21 |
ASX - By Stock
|
1.4K
|
554K
|
2
|
|
ASX - By Stock
|
IIQ |
Re:
Chart Thread
|
|
Locked
|
1.4K |
554K |
7 |
17/03/21 |
17/03/21 |
ASX - By Stock
|
1.4K
|
554K
|
7
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Positive Results Evaluation of EXO-NET in Pancreatic Cancer
|
|
Locked
|
146 |
51K |
2 |
16/03/21 |
16/03/21 |
ASX - By Stock
|
146
|
51K
|
2
|
|
ASX - By Stock
|
MEM |
Re:
Steady climb
|
|
Locked
|
34 |
9.9K |
1 |
12/02/21 |
12/02/21 |
ASX - By Stock
|
34
|
9.9K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MPC-06-ID Phase 3 results countdown
|
|
Locked
|
273 |
141K |
10 |
23/12/20 |
23/12/20 |
ASX - By Stock
|
273
|
141K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
MPC-06-ID Phase 3 results countdown
|
|
Locked
|
273 |
141K |
5 |
23/12/20 |
23/12/20 |
ASX - By Stock
|
273
|
141K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
MPC-06-ID Phase 3 results countdown
|
|
Locked
|
273 |
141K |
2 |
20/12/20 |
20/12/20 |
ASX - By Stock
|
273
|
141K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MPC-06-ID Phase 3 results countdown
|
|
Locked
|
273 |
141K |
6 |
20/12/20 |
20/12/20 |
ASX - By Stock
|
273
|
141K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on COVID-19 ARDS Trial
|
|
Locked
|
1.0K |
517K |
5 |
20/12/20 |
20/12/20 |
ASX - By Stock
|
1.0K
|
517K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading halt
|
|
Locked
|
796 |
394K |
9 |
17/12/20 |
17/12/20 |
ASX - By Stock
|
796
|
394K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
Locked
|
13K |
5.0M |
0 |
26/11/20 |
26/11/20 |
ASX - By Stock
|
13K
|
5.0M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
Locked
|
13K |
5.0M |
12 |
26/11/20 |
26/11/20 |
ASX - By Stock
|
13K
|
5.0M
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Cynata claiming their cells far superior to MSB's
|
|
Locked
|
17 |
7.7K |
4 |
18/11/20 |
18/11/20 |
ASX - By Stock
|
17
|
7.7K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Locked
|
17K |
6.7M |
5 |
31/10/20 |
31/10/20 |
ASX - By Stock
|
17K
|
6.7M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment
|
|
Locked
|
445 |
193K |
16 |
13/10/20 |
13/10/20 |
ASX - By Stock
|
445
|
193K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Locked
|
17K |
6.7M |
0 |
15/05/20 |
15/05/20 |
ASX - By Stock
|
17K
|
6.7M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Locked
|
17K |
6.7M |
4 |
15/05/20 |
15/05/20 |
ASX - By Stock
|
17K
|
6.7M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MSB Monday Opening Price
|
|
Locked
|
312 |
156K |
4 |
27/04/20 |
27/04/20 |
ASX - By Stock
|
312
|
156K
|
4
|
|
ASX - By Stock
|
PNV |
Re:
Ann: Letter to Shareholders
|
|
Locked
|
86 |
30K |
9 |
11/03/20 |
11/03/20 |
ASX - By Stock
|
86
|
30K
|
9
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Chart
|
|
Locked
|
19K |
11M |
11 |
09/03/20 |
09/03/20 |
ASX - By Stock
|
19K
|
11M
|
11
|
|